HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
New Exactech Knee Research Demonstrates Ability to Achieve Balanced Results with Short Learning Curve Using Newton™ Technology
Exactech Knee notes the new study, which reviewed the first 273 surgeries using Exactech’s Newton Knee balancing system, demonstrated the ability of surgeons to achieve targeted gap balance throughout each patient’s range of motion.
10-Year Data from the Medtronic ENGAGE OUS Registry is the First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of...
The ENGAGE OUS registry evaluated more than 1,200 patients. The 10-year data, which included follow-up from approximately 400 of these patients, showed a 94.7 percent freedom from aneurysm-related mortality (ARM) † and 64.1 percent sac regression (or decreased AAA sac diameter) ‡ at 10 years.
Nevro Announces Enrollment of First Patient in PDN Sensory Study
The PDN Sensory Study will enroll up to 236 patients at multiple sites across the U.S. Patients will be randomized to conventional medical management or 10 kHz Therapy™ plus conventional medical management, with optional crossover to the other treatment arm at 6 months if those criteria are met.
Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Ground-Breaking Proof-of-Principle Study
“Proof-of-principle studies are critical in demonstrating Bio-RFID accuracy for non-invasive methods of medical diagnostics. This was an essential step toward achieving our goal of delivering the first FDA-cleared, truly non-invasive glucose monitoring device to the market,” said Ron Erickson, CEO and Chairman at Know Labs.
Watkins-Conti Completes Stress Urinary Incontinence Yōni.Fit Device Trial
Seventy one (71) participants enrolled in a randomized, controlled, single-blind, multi-center study of the Yōni.Fit device in women with stress urinary incontinence.
NICO Corporation’s ENRICH Trial Evaluating Minimally Invasive Parafascicular Surgery (MIPS) for Intracerebral Hemorrhage (ICH) to be Presented at the 2023 AANS Annual Scientific Meeting...
The ENRICH trial results were accepted as a late-breaker and will be presented on Saturday, April 22 during an oral plenary session beginning at 8:30 a.m. PT (11:30 a.m. ET) by co-lead ENRICH investigator, Gustavo Pradilla, M.D., associate professor of neurosurgery at Emory University School of Medicine and chief of neurosurgery at Grady Memorial Hospital.
Ancora Heart and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
Mark Miles, chief commercial officer of Ancora Heart. “This partnership with egnite and The Christ Health Network will allow us to deploy AI tools such as egnite’s Trial Accelerator and expedite identification of eligible candidates for the CORCINCH-HF trial.”
Study Links “Stuck” Stem Cells to Hair Turning Gray
The researchers found that as hair ages, sheds, and then repeatedly grows back, increasing numbers of McSCs get stuck in the stem cell compartment called the hair follicle bulge. There, they remain, do not mature into the transit-amplifying state, and do not travel back to their original location in the germ compartment, where WNT proteins would have prodded them to regenerate into pigment cells.
Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis
Data shows the achievement of the primary endpoint of decreasing esophageal intraepithelial eosinophil count and the positive impact on an array of histological measures of EoE. Favorable safety and tolerability profile consistent with Phase 1 trial results.
